■这篇综述讨论了基于脂质体制剂的新型混合组装体。重点在于通过脂质体/囊泡与其他纳米物体如核酸纳米结构和金属纳米颗粒的整合形成的杂合构建体。目的是介绍一些最近,桥梁不同技术的具体例子,因此可能形成先进的药物输送应用的新平台。
■我们介绍了脂质体制剂与复杂纳米结构结合的示例,这些纳米结构基于DNA折纸等生物分子或金属材料-金属/金属氧化物/磁性颗粒和金属纳米结构,例如金属有机框架-以及它们在药物输送和超越中的应用。
■合并上述技术可以导致开发具有最理想特性的药物递送载体;多功能,生物相容性,高药物装载效率/准确性/容量,和刺激反应。在不久的将来,我们认为,特别是结合动态的战略,可触发和可编程的DNA纳米结构和脂质体可用于创建用于多种应用的人工脂质体簇,例如检查脂质双层之间的蛋白质介导的相互作用和脂质体之间的通道材料,以增强药物递送中的药代动力学特性。
UNASSIGNED: This review discusses novel hybrid assemblies that are based on liposomal formulations. The focus is on the hybrid constructs that are formed through the integration of liposomes/vesicles with other nano-objects such as nucleic acid nanostructures and metallic nanoparticles. The aim is to introduce some of the recent, specific examples that bridge different technologies and thus may form a new platform for advanced drug delivery applications.
UNASSIGNED: We present selected examples of liposomal formulations combined with complex nanostructures either based on biomolecules like DNA origami or on metallic materials - metal/metal oxide/magnetic particles and metallic nanostructures, such as metal organic frameworks - together with their applications in drug delivery and beyond.
UNASSIGNED: Merging the above-mentioned techniques could lead to development of drug delivery vehicles with the most desirable properties; multifunctionality, biocompatibility, high drug loading efficiency/accuracy/capacity, and stimuli-responsiveness. In the near future, we believe that especially the strategies combining dynamic, triggerable and programmable DNA nanostructures and liposomes could be used to create artificial liposome clusters for multiple applications such as examining protein-mediated interactions between lipid bilayers and channeling materials between liposomes for enhanced pharmacokinetic properties in drug delivery.